Filter
13909
Filtered Results: 13909
Text search:
développement
Featured
Recommendations
1048
New Publications
3541
Language
Document type
No document type
7887
Studies & Reports
2456
Guidelines
1484
Manuals
609
Strategic & Response Plan
504
Fact sheets
368
Training Material
242
Situation Updates
120
Resource Platforms
80
Infographics
80
Brochures
39
Online Courses
22
Videos
11
Dashboards/Maps
4
App
3
Countries / Regions
Global
587
India
491
Kenya
364
Ethiopia
275
Nepal
258
South Africa
239
Sierra Leone
236
Congo, Democratic Republic of
235
Uganda
235
Myanmar / Burma
235
Nigeria
229
Liberia
207
Senegal
201
Western and Central Europe
200
Africa
192
Rwanda
189
Malawi
182
Latin America and the Carribbean
181
Zambia
171
Bangladesh
170
Tanzania
158
Burkina Faso
153
Syria
149
Indonesia
140
Ukraine
139
Ghana
135
Haiti
117
Philippines
112
Benin
112
Guinea
105
Namibia
97
Eastern Europe
92
Lesotho
89
Russia
89
Zimbabwe
86
South Sudan
86
Cambodia
85
Mozambique
84
Cameroon
79
South–East Asia Region
78
West and Central Africa
77
Asia
70
Yemen
67
East and Southern Africa
67
Germany
66
Central African Republic
64
Brazil
61
Middle East and North Africa
60
Venezuela
56
Mali
53
Botswana
51
Madagascar
50
Colombia
47
Eastern Europe and Central Asia
45
Afghanistan
40
Eswatini/ Swaziland
39
Pakistan
37
Côte d’Ivoire / Ivory Coast
36
Lebanon
32
Sudan
32
Jordan
29
Niger
27
Somalia
27
Paraguay
26
Thailand
25
Western Pacific Region
25
Vietnam
24
Peru
23
Iraq
22
Argentina
22
USA
21
China
20
Tajikistan
20
Togo
18
Moldova
17
Chad
16
Burundi
15
Sri Lanka
15
Chile
15
Albania
15
Ecuador
14
Angola
14
Turkey
12
Laos
12
Libya
11
Palestine
11
Papua New Guinea
10
Georgia
10
Egypt
9
Mexico
9
Southern Africa
9
Iran
9
North America
9
Guinea-Bissau
8
Morocco
8
North Macedonia
8
France
8
United Kingdom
8
Honduras
7
Bolivia
7
Poland
7
Armenia
7
Canada
7
Kyrgyzstan
7
Kazakhstan
7
Portugal
7
Gambia
6
Hungary
6
El Salvador
6
Guatemala
6
Bhutan
6
Timor Leste/ East Timor
6
Romania
6
Jamaica
6
Spain
6
Saudi Arabia
5
Malaysia
5
Turkmenistan
5
Japan
5
Tunisia
5
Mauritania
4
Serbia
4
Greece
4
Fiji
4
Congo-Brazzaville
4
Uzbekistan
4
Gabon
4
Belarus
4
Singapore
3
Croatia
3
Djibouti
3
Estonia
3
Mauritius
3
Bosnia and Herzegovina
3
Vanuatu
2
Dominican Republic
2
Switzerland
2
Nicaragua
2
Other region
2
North Korea
2
Italy
2
Mongolia
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
Belgium
2
Algeria
2
Azerbaijan
2
Israel
2
Ireland
1
Luxembourg
1
Solomon Islands
1
Australia
1
Uruguay
1
Denmark
1
Maldives
1
Norway
1
Latvia
1
Barbados
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
5290
Clinical Guidelines
885
Women & Child Health
735
Public Health
723
Key Resources
622
Capacity Building
263
Pharmacy & Technologies
112
Annual Report MEDBOX
3
Toolboxes
Mental Health
1098
COVID-19
1084
HIV
862
Disability
667
TB
624
Planetary Health
568
Caregiver
400
Ebola
398
AMR
382
Conflict
365
Rapid Response
364
NTDs
308
Refugee
275
Global Health Education
272
NCDs
271
Health Financing Toolbox
219
Pharmacy
215
Natural Hazards
202
Zika
102
Social Ethics
93
Cholera
80
Specific Hazards
66
Polio
61
Typhoon
6
Health Financing
4
South Sudan
2
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
In an era of digital, democratic, societal and political change, communication has become more than ever a gateway for revolutionary ideas and initiatives, capable of creating stronger, more informed and more engaged communities than ever before. The emergence of ethical journalism has become centra...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical ..., and operational challenges of the clinical trials of fexinidazole. The screening of the Drugs for Neglected Diseases initiative (DNDi) HAT-library by the Swiss TPH had singled out fexinidazole, originally developed by Hoechst (now Sanofi), as the most promising of a series of over 800 nitroimidazoles and related molecules. In cell culture, fexinidazole has an IC50 of around 1 µM against Trypanosoma brucei and is more than 100-fold less toxic to mammalian cells. In the mouse model, fexinidazole cures both the first, haemolymphatic, and the second, meningoencephalitic stage of the infection, the latter at 100 mg/kg twice daily for 5 days. In patients, the clinical trials managed by DNDi and supported by Swiss TPH mainly conducted in the Democratic Republic of the Congo demonstrated that oral fexinidazole is safe and effective for use against first- and early second-stage sleeping sickness. Based on the positive opinion issued by the European Medicines Agency in 2018, the WHO has released new interim guidelines for the treatment of HAT including fexinidazole as the new therapy for first-stage and non-severe second-stage sleeping sickness caused by Trypanosoma brucei gambiense (gHAT). This greatly facilitates the diagnosis and treatment algorithm for gHAT, increasing the attainable coverage and paving the way towards the envisaged goal of zero transmission by 2030.
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
Treatment of second-stage gambiense human African trypanosomiasis relied on toxicarsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine,initially in monotherapy and more recently in combination with nifurtimox (NECT), has drasticallyimproved the pro...
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...
The control of schistosomiasis was a high priority in China soon after the founding of the People’s Republic of China in 1949, and schistosomiasis japonica was largely brought under control through 7 decades of effort. However, great challenges still exist to completely eliminate schistosomiasis f...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector ... time, reduce Leishmania parasite incubation time, and increase vector biting rates, allowing transmission
in areas not previously endemic for the disease. Poor and
marginalized communities will be hit disproportionately harder by
the effects of climate change, and droughts, famines, and floods
can also lead to displacement and migration of immunologically
naive people to areas where leishmaniasis is endemic, posing a
threat of leishmaniasis outbreaks.
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
UNICEF, WHO Whole of Syria Nutrition, Cluster, the Global Nutrition Cluster, the IFE Core Group, and partners call for ALL involved in the response to the earthquakes in Syria to protect, promote, and support the feeding and care of infants and young children, their caregivers, especially pregnant, ...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
One of the 16 Pledge commitments asked CEOs to “[r]ecognize the immediate and long-term effects sexual abuse, exploitation, and harassment have on [NGO] staff and the people [they] serve, and [to] … ensure [their] organizations have robust policies and funded mechanisms to provide the necessary ...
Human scabies is a parasitic infestation caused by Sarcoptes scabiei var hominis. The microscopic mite burrows into the skin and lays eggs, eventually triggering a host immune response that leads to intense itching and rash. Scabies infestation may be complicated by bacterial infection, leading to t...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
